As rates of depression and anxiety have amplified dramatically, individuals have sought therapies outside the typical program of oral antidepressants and chat therapy. Starting during the mid-2010s, more and more doctors started offering ketamine as being a treatment for depression. In 2019, the Food and Drug Administration (FDA) approved esketamin